Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Dekker

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Cell Science|July 17, 2012
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cellsKaamar Azijli, Saravanan Yuvaraj, Maikel P Peppelenbosch, et al.
Cancers|December 23, 2022
High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid TumorsSophie L Gerritse, Mariette Labots, Rob Ter Heine, et al.
Cancer Medicine|September 1, 2020
A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancerDennis Poel, Elske C Gootjes, Lotte Bakkerus, et al.
The Oncologist|July 19, 2018
Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling StudyMariette Labots, Johannes C Van der Mijn, Henk Dekker, et al.
Oncoscience|January 27, 2015
Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculatureKristy J Gotink, Henk J Broxterman, Richard J Honeywell, et al.
International Journal of Molecular Sciences|August 7, 2021
Effects of Cancer Presence and Therapy on the Platelet ProteomeMaudy Walraven, Siamack Sabrkhany, Jaco C Knol, et al.
Journal of Extracellular Vesicles|December 11, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancerJohannes C van der Mijn, Nik Sol, Wouter Mellema, et al.
Cancer Medicine|March 14, 2023
Advancing wide implementation of precision oncology: A liquid nitrogen-free snap freezer preserves molecular profiles of biological samplesHanneke van der Wijngaart, Sahil Jagga, Henk Dekker, et al.
Journal of Proteomics|April 27, 2017
Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selectionMariette Labots, Johannes C van der Mijn, Robin Beekhof, et al.
International Journal of Cancer|January 28, 2016
Sunitinib activates Axl signaling in renal cell cancerJohannes C van der Mijn, Henk J Broxterman, Jaco C Knol, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Cell Science|July 17, 2012
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cellsKaamar Azijli, Saravanan Yuvaraj, Maikel P Peppelenbosch, et al.
Cancers|December 23, 2022
High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid TumorsSophie L Gerritse, Mariette Labots, Rob Ter Heine, et al.
Cancer Medicine|September 1, 2020
A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancerDennis Poel, Elske C Gootjes, Lotte Bakkerus, et al.
The Oncologist|July 19, 2018
Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling StudyMariette Labots, Johannes C Van der Mijn, Henk Dekker, et al.
Oncoscience|January 27, 2015
Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculatureKristy J Gotink, Henk J Broxterman, Richard J Honeywell, et al.
International Journal of Molecular Sciences|August 7, 2021
Effects of Cancer Presence and Therapy on the Platelet ProteomeMaudy Walraven, Siamack Sabrkhany, Jaco C Knol, et al.
Journal of Extracellular Vesicles|December 11, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancerJohannes C van der Mijn, Nik Sol, Wouter Mellema, et al.
Cancer Medicine|March 14, 2023
Advancing wide implementation of precision oncology: A liquid nitrogen-free snap freezer preserves molecular profiles of biological samplesHanneke van der Wijngaart, Sahil Jagga, Henk Dekker, et al.
Journal of Proteomics|April 27, 2017
Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selectionMariette Labots, Johannes C van der Mijn, Robin Beekhof, et al.
International Journal of Cancer|January 28, 2016
Sunitinib activates Axl signaling in renal cell cancerJohannes C van der Mijn, Henk J Broxterman, Jaco C Knol, et al.
Pageof 4